Mindfulness-based Cognitive Therapy (MBCT) for People With Parkinson's Disease

Completed · Not applicable

Conditions studied: Parkinson Disease, Anxiety, Depression

In brief

This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease.

Key facts

Study ID

NCT03904654

Run by

University of California, San Francisco

People needed

16

Starts

2019-08-26

Expected to finish

2020-04-06

Last updated by the study team

2020-05-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Parkinson's disease or parkinsonism (established by a neurologist)
• Living in the San Francisco Bay Area
• Being able and willing to attend 8 weekly 90-minute group sessions
• Mild-to-moderate anxiety: GAD-7 score ≤ 16
• Mild-to-moderate depression: PHQ-9 score ≤ 18

You may not qualify if…

• Severe anxiety: GAD-7 score > 16
• Moderately severe-to-severe depression: PHQ-9 score > 18
• Cognitive impairment: Montreal Cognitive Assessment (MoCA) score < 24
• Heavy alcohol or drug use
• Severe psychosis
• Active suicidal or homicidal ideation
• Severe motor fluctuations (less than 2 hours "on" time per day)

Where it is running

• University of California, San Francisco — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.